Thromb Haemost 1981; 46(03): 593-596
DOI: 10.1055/s-0038-1653425
Original Article
Schattauer GmbH Stuttgart

Radiolabeling of Fibrinogen Using the Iodogen Technique

Authors

  • Linda C Knight

    The Thrombosis Research Center and Department of Biochemistry, Temple University Health Sciences Center, Philadelphia, Pennsylvania, U.S.A
  • Andrei Z Budzynski

    The Thrombosis Research Center and Department of Biochemistry, Temple University Health Sciences Center, Philadelphia, Pennsylvania, U.S.A
  • Stephanie A Olexa

    The Thrombosis Research Center and Department of Biochemistry, Temple University Health Sciences Center, Philadelphia, Pennsylvania, U.S.A
Further Information

Publication History

Received 16 March 1981

Accepted 24 June 1981

Publication Date:
05 July 2018 (online)

Summary

The properties of human fibrinogen labeled with 125-Iodine using Iodogen (1, 3, 4, 6-tetrachloro-3α, 6α-diphenylglycoluril) as an oxidizing agent were compared with those of an iodine monochloride labeled counterpart. It was found that thrombin clottability, binding to staphylococci, the relative specific radioactivity of the Aα, Bβ, and γ chains and in vivo clearance from plasma in rabbits were the same in these two labeled fibrinogen preparations. Labeling efficiency was higher when iodogen was used. It is concluded that human fibrinogen labeled with radioiodine using the Iodogen technique is suitable for studies in vitro and in vivo.